Boxer Capital LLC 13D and 13G filings for Mereo BioPharma Group plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:40 pm Sale |
2021-12-31 | 13G | Mereo BioPharma Group plc MREO |
Boxer Capital LLC | 4,082,576 3.600% |
-6,226,674 (-60.40%) |
Filing |
| 2021-02-16 4:29 pm Sale |
2020-12-31 | 13G | Mereo BioPharma Group plc MREO |
Boxer Capital LLC | 10,309,250 9.100% |
-10,052,625 (-49.37%) |
Filing |
| 2020-06-05 4:31 pm Purchase |
2020-06-03 | 13G | Mereo BioPharma Group plc MREO |
Boxer Capital LLC | 20,361,875 9.500% |
8,109,160 (+66.18%) |
Filing |